EXPLORE THE UNIVERSITY OF OXFORD'S WORLD-CLASS RESEARCH

1 entry found
1
Journal article icon
Journal article

Dual Erb B Inhibition in Oesophago-gastric Cancer (DEBIOC): A phase I dose escalating safety study and randomised dose expansion of AZD8931 in combination with oxaliplatin and capecitabine chemotherapy in patients with oesophagogastric adenocarcinoma

  • Thomas, A, Virdee, PS, Martin, E, et al.
  • 2019-11-22
File available icon
Peer reviewed icon
Link to publisher copy available icon
FILTER RESULTS

TO TOP